Gene expression of IGF1, IGF1R, and IGFBP3 in epiretinal membranes of patients with proliferative diabetic retinopathy: Preliminary study

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Romaniuk, Dorota ^a   Kimsa, Malgorzata W ^a   Strzalka Mrozik, Barbara ^a   Kimsa, Magdalena C ^a   Kabiesz, Adam ^a   Romaniuk, Wanda ^a   Mazurek, Urszula ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

IGF1 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

AGED; ARTICLE; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY; VITREORETINOPATHY;

AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEUKOCYTES, MONONUCLEAR; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84893819836     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/986217     Document Type: Article

References (44)

1. Abu El-Asrar A. M., Imtiaz Nawaz M., Kangave D., Siddiquei M. M., Geboes K., Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders. Mediators of Inflammation 2012 2012 8 10.1155/2012/493043 493043
2. Snead D. R. J., James S., Snead M. P., Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation. Eye 2008 22 10 1310 1317 2-s2.0-54249167929 10.1038/eye.2008.36
3. Smiddy W. E., Maguire A. M., Green W. R., Michels R. G., de la Cruz Z., Enger C., Jaeger M., Rice T. A., Idiopathic epiretinal membranes: ultrastructural characteristics and clinicopathologic correlation. 1989. Retina 2005 25 5 811 821 2-s2.0-24044490931
4. Yazici A. T., Alagöz N., Çelik H. U., Bozkurt E., Alagöz C., Çakir M., Çekiç O., Yilmaz Ö. F., Idiopathic and secondary epiretinal membranes: do they differ in terms of morphology? An optical coherence tomography-based study. Retina 2011 31 4 779 784 2-s2.0-79955064241 10.1097/IAE.0b013e3181ef8786
5. Zhang X., Barile G., Chang S., Hays A., Pachydaki S., Schiff W., Sparrow J., Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expres (Pubitemid 40910820)
6. Oberstein S. Y. L., Byun J., Herrera D., Chapin E. A., Fisher S. K., Lewis G. P., Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Molecular Vision 2011 17 1794 1805 2-s2.0-79960703328
7. Yamaji Y., Yoshida S., Ishikawa K., Sengoku A., Sato K., Yoshida A., Kuwahara R., Ohuchida K., Oki E., Enaida H., Fujisawa K., Kono T., Ishibashi T., TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy. Investigative Ophthalmology and Visual Science 2008 49 7 3151 3157 2-s2.0-48249156147 10.1167/iovs.07-1249
8. Harada C., Mitamura Y., Harada T., The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells. Progress in Retinal and Eye Research 2006 25 2 149 164 2-s2.0-32444439339 10.1016/j.preteyeres.2005.09.001 (Pubitemid 43227842)
9. Bringmann A., Wiedemann P., Involvement of Müller glial cells in epiretinal membrane formation. Graefe's Archive for Clinical and Experimental Ophthalmology 2009 247 7 865 883 2-s2.0-67349255284 10.1007/s00417-009-1082-x
10. Iannetti L., Accorinti M., Malagola R., Bozzoni-Pantaleoni F., da Dalt S., Nicoletti F., Gradini R., Traficante A., Campanella M., Pivetti-Pezzi P., Role of the intravitreal growth factors in the pathogenesis of idiopathic epiretinal membrane. Investigative Ophthalmology and Visual Science 2011 52 8 5786 5789 2-s2.0-80053325441 10.1167/iovs.10-7116
11. Simó R., Carrasco E., García-Ramírez M., Hernández C., Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Current Diabetes Reviews 2006 2 1 71 98 10.2174/157339906775473671 (Pubitemid 44082952)
12. Spraul C. W., Kaven C., Amann J., Lang G. K., Lang G. E., Effect of insulin-like growth factors 1 and 2, and glucose on the migration and proliferation of bovine retinal pigment epithelial cells in vitro. Ophthalmic Research 2000 32 5 244 248 2-s2.0-0033832562
13. Payne J. F., Tangpricha V., Cleveland J., Lynn M. J., Ray R., Srivastava S. K., Serum insulin-like growth factor-I in diabetic retinopathy. Molecular Vision 2011 17 2318 2324 2-s2.0-80053034581
14. Chen H.-S., Wu T.-E., Hsiao L.-C., Lin S.-H., Interaction between glycaemic control and serum insulin-like growth factor 1 on the risk of retinopathy in type 2 diabetes. European Journal of Clinical Investigation 2012 42 4 447 454 2-s2.0-84858294233 10.1111/j.1365-2362.2011.02616.x
15. Haurigot V., Villacampa P., Ribera A., Llombart C., Bosch A., Nacher V., Ramos D., Ayuso E., Segovia J. C., Bueven J. A., Ruberte J., Bosch F., Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown. The Journal of Biological Chemistry 2009 284 34 22961 22969 2-s2.0-69249110875 10.1074/jbc.M109.014787
16. Lee M. J., Shin D. H., Ko K. I., Koo H. M., Kim C. H., Doh F. M., Oh H. J., Han S. H., Yoo T. H., Kim B. S., Kang S. W., Choi K. H., Association between the ratio of insulin-like growth factor-I to insulin-like growth factor binding protein-3 and inflammation in incident automated peritoneal dialysis patients. Growth Hormone and IGF Research 2013 23 5 170 174 10.1016/j.ghir.2013.06.004
17. Kluge A., Zimmermann R., Weihrauch D., Mohri M., Sack S., Schaper J., Schaper W., Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart. Cardiovascular Research 1997 33 2 324 331 2-s2.0-0031028605 10.1016/S0008-6363(96)00236-2 (Pubitemid 27072637)
18. Strzalka-Mrozik B., Nowak A., Gola J., Kowalczyk M., Kapral M., Mazurek U., Factors associated with changes in endothelin-1 gene expression in patients with diabetic retinopathy in type 2 diabetes mellitus. Molecular Vision 2010 16 1272 1279 2-s2.0-77955652341
19. Guidry C., King J. L., Isolation and characterization of vitreous insulin-like growth factor binding proteins. Investigative Ophthalmology and Visual Science 2011 52 1 303 309 2-s2.0-79952238120 10.1167/iovs.10-5920
20. Burren C. P., Berka J. L., Edmondson S. R., Werther G. A., Batch J. A., Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye. Investigative Ophthalmology and Visual Science 1996 37 7 1459 1468 2-s2.0-0029936066 (Pubitemid 26177322)
21. Wu Y. C., Buckner B. R., Zhu M., Cavanagh H. D., Robertson D. M., Elevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epithelium. The Ocular Surface 2012 10 2 100 107 10.1016/j.jtos.2012.01.004
22. Sengupta N., Afzal A., Caballero S., Chang K.-H., Shaw L. C., Pang J.-J., Bond V. C., Bhutto I., Baba T., Lutty G. A., Grant M. B., Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization. Investigative Ophthalmology and Visual Science 2010 51 5 2697 2704 2-s2.0-77952527827 10.1167/iovs.09-4137
23. Berezowski P., Strzalka-Mrozik B., Forminska-Kapuscik M., Mazurek U., Filipek E., Nawrocka L., Pieczara E., Banasiak P., Kimsa M., Posttraumatic temporal TGF- β mRNA expres sion in lens epithelial cells of paediatric patients. Folia Biologica 2012 58 24 29
24. Kapral M., Wawszczyk J., Jurzak M., Hollek A., Weglarz L., The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1 β -stimulated colon cancer cells. International Journal of Colorectal Disease 2012 27 11 1419 1428 2-s2.0-84857929646 10.1007/s00384-012-1445-3
25. Takagi H., Yoshimura N., Tanihara H., Honda Y., Insulin-like growth factor-related genes, receptors, and binding proteins in cultured human retinal pigment epithelial cells. Investigative Ophthalmology and Visual Science 1994 35 3 916 923 2-s2.0-0028270554 (Pubitemid 24079822)
26. Moriarty P., Boulton M., Dickson A., McLeod D., Production of IGF-I and IGF binding proteins by retinal cells in vitro. British Journal of Ophthalmology 1994 78 8 638 642 2-s2.0-0027967036 (Pubitemid 24249162)
27. Spoerri P. E., Ellis E. A., Tarnuzzer R. W., Grant M. B., Insulin-like growth factor: receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin. Growth Hormone and IGF Research 1998 8 2 125 132 2-s2.0-0032461171 (Pubitemid 29119476)
28. King J. L., Guidry C., Vitreous IGFBP-3 effects on Müller cell proliferation and tractional force generation. Investigative Ophthalmology & Visual Science 2012 53 1 93 99 2-s2.0-84857987822
29. Spoerri P. E., Caballero S., Wilson S. H., Shaw L. C., Grant M. B., Expression of IGFBP-3 by human retinal endothelial cell cultures: IGFBP-3 involvement in growth inhibition and apoptosis. Investigative Ophthalmology and Visual Science 2003 44 1 365 369 2-s2.0-0037250470 10.1167/iovs.02-0309 (Pubitemid 36134297)
30. Kielczewski J. L., Hu P., Shaw L. C., Li Calzi S., Mames R. N., Gardiner T. A., McFarland E., Chan-Ling T., Grant M. B., Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury. The American Journal of Pathology 2011 178 4 1517 1528 2-s2.0-79953672049 10.1016/j.ajpath.2010.12.031
31. Zhang Q., Soderland C., Steinle J. J., Regulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor. Apoptosis 2013 18 3 361 368 10.1007/s10495-012-0793-3
32. Regan F. M., Williams R. M., McDonald A., Umpleby A. M., Acerini C. L., O'Rahilly S., Hovorka R., Semple R. K., Dunger D. B., Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance. Journal of Clinical Endocrinology and Metabolism 2010 95 5 2113 2122 2-s2.0-77952784903 10.1210/jc.2009-2088
33. Ruberte J., Ayuso E., Navarro M., Carretero A., Nacher V., Haurigot V., George M., Llombart C., Casellas A., Costa C., Bosch A., Bosch F., Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. Journal of Clinical Investigation 2004 113 8 1149 1157 2-s2.0-11144354304 10.1172/JCI200419478 (Pubitemid 38544100)
34. Burgos R., Mateo C., Cantón A., Hernández C., Mesa J., Simó R., Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care 2000 23 1 80 83 2-s2.0-0033961452 (Pubitemid 30022899)
35. Meyer-Schwickerath R., Pfeiffer A., Blum W. F., Freyberger H., Klein M., Losche C., Rollmann R., Schatz H., Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. Journal of Clinical Investigation 1993 92 6 2620 2625 2-s2.0-0027143188 (Pubitemid 24006525)
36. Spranger J., Bühnen J., Jansen V., Krieg M., Meyer-Schwickerath R., Blum W. F., Schatz H., Pfeiffer A. F. H., Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IFG-BP3 in proliferative diabetic retinopathy. Hormone and Metabolic Research 2000 32 5 196 200 2-s2.0-0034096960 (Pubitemid 30353756)
37. Gerhardinger C., McClure K. D., Romeo G., Podestà F., Lorenzi M., IGF-I mRNA and signaling in the diabetic retina. Diabetes 2001 50 1 175 183 2-s2.0-0035149745 (Pubitemid 32047997)
38. Wang Q., Dills D. G., Klein R., Klein B. E. K., Moss S. E., Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy? Diabetes 1995 44 2 161 164 2-s2.0-0028944958
39. Dills D. G., Moss S. E., Klein R., Klein B. E. K., Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes. Diabetes 1991 40 12 1725 1730 2-s2.0-0026343661
40. Merimee T. J., Zapf J., Froesch E. R., Insulin-like growth factors. Studies in diabetics with and without retinopathy. The New England Journal of Medicine 1983 309 9 527 530 2-s2.0-0020550445 (Pubitemid 13037239)
41. Kase S., Saito W., Ohno S., Ishida S., Proliferative diabetic retinopathy with lymphocyte-rich epiretinal membrane associated with poor visual prognosis. Investigative Ophthalmology and Visual Science 2009 50 12 5909 5912 2-s2.0-73349096024 10.1167/iovs.09-3767
42. Praidou A., Klangas I., Papakonstantinou E., Androudi S., Georgiadis N., Karakiulakis G., Dimitrakos S., Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy. Current Eye Research 2009 34 2 152 161 2-s2.0-60749113763 10.1080/02713680802585920
43. Praidou A., Papakonstantinou E., Androudi S., Georgiadis N., Karakiulakis G., Dimitrakos S., Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema. Acta Ophthalmologica 2011 89 3 248 254 2-s2.0-79955015955 10.1111/j.1755-3768.2009.01661.x
44. Cantón A., Burgos R., Hernández C., Mateo C., Segura R. M., Mesa J., Simó R., Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy. British Journal of Ophthalmology 2000 84 7 732 735 2-s2.0-0033932964 10.1136/bjo.84.7.732 (Pubitemid 30438551)